BiVACOR
Huntington Beach, US · Delaware corporation · 1 known investors
BiVACOR is a clinical-stage medical device company developing a Total Artificial Heart (TAH), an electro-mechanical rotary blood pump with a single magnetically levitated rotor that replaces both ventricles for patients with end-stage biventricular heart failure. The device is undergoing an FDA-approved first-in-human Early Feasibility Study as a bridge-to-transplant solution.
Founders & leadership
DT
Daniel TimmsFounder & Chief Technical Officer
JD
James DillonExecutive Officer, Director
WE
William E. CohnDirector
TV
Tom VassiliadesExecutive Officer, Director
WC
William CohnChief Medical Officer
BC
Bihua ChenDirector
PK
Paul KellyDirector
MM
Matt MackeyDirector
RK
Raymond KelleherDirector
RW
Raymond W. CohenDirector
JJ
Jeannette JoughinDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$9MraisedAug 2024 · 3 investors · Other TechnologyRule 506(b)
▶$9MraisedAug 2024 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matt MackeyDirector
- Raymond KelleherDirector
- Daniel TimmsExecutive Officer, Director
- Bihua ChenDirector
- Raymond W. CohenDirector
- Jeannette JoughinDirector
- James DillonExecutive Officer, Director
- Paul KellyDirector
- Offering amount
- $28M
- Amount sold
- $9M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedFeb 2023 · 4 investors · Other TechnologyRule 506(b)
▶$15MraisedFeb 2023 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William E. CohnDirector
- Jeannette JoughinDirector
- Paul KellyDirector
- Raymond KelleherDirector
- Daniel TimmsExecutive Officer, Director
- Matt MackeyDirector
- Bihua ChenDirector
- Tom VassiliadesExecutive Officer, Director
- Offering amount
- $36M
- Amount sold
- $15M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.